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Background: Adverse soft-tissue reaction to metal debris (ARMD) continues to be major source of concern in
metal-on-metal (MoM) hip replacements. In our earlier study we were able to establish several risk factors for ARMD
in patients who had received a small-diameter (<50 mm) Articular Surface Replacement (ASR, DePuy, Warsaw, IN,
USA). The aims of the present study were to analyze whether these previously established risk factors also apply to
patients who have received a large-headed (>50 mm) ASR™ XL THR.
Methods: Large-headed ASR total hip replacements were used in 225 operations (196 patients) at our institution.
176 patients (203 hips) attended a screening programme, consisting of a clinical evaluation, whole blood cobalt
and chromium measurements, and cross-sectional imaging.
Results: Revision surgery was performed on 84 hips (37%) in 75 patients. ARMD was diagnosed in the majority
(n = 73 [87%]) of these revisions. Cumulative 8-year survivorship was 52%. The previously established risk factors for
ARMD were not applicable. Interestingly, increasing femoral diameter and stem type were identified as independent
risk factors for ARMD but reduced cup coverage had no significant association with ARMD.
Conclusions: Stem type and increasing femoral size as independent risk factors for ARMD in the cohort of ASR XL
THR patients, support the importance of taper failure in the development of ARMD. The present results suggest that
the degree of taper failure may be variable and dependent on the taper design.
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Adverse soft-tissue reaction to metal debris (ARMD)
continues to be a major source of concern in metal-on-
metal (MoM) hip replacements. In addition to Articular
Surface Replacement (ASR™; DePuy, Warsaw, IN, USA)
several other large-diameter metal-on-metal (LD-MoM)
total hip replacements (THR) have been recalled along
with Medical Device Alerts owing to high prevalence of
ARMD [1,2]. It is well known that a major aetiological
factor resulting in failure in MoM THRs is excessive
wear originating from the taper surface [3-5]. According
to registry studies and clinical patient series, however,
MoM hip resurfacing (HR) seems to be successful only if
large femoral sizes (>50 mm) are used [6-9].* Correspondence: Aleksi.reito@fimnet.fi
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unless otherwise stated.In earlier study we were able to identify several risk fac-
tors for ARMD in patients who had received a small-
diameter (<50 mm) ASR hip replacement [10]. Small
femoral diameter alone has been associated with an in-
creased risk of ARMD [11,12]. With increasing femoral
size articular coverage increases due to larger hemisphere
of the cup [13]. This further reduces the risk of edge-
loading [14,15]. However, the prevalence of ARMD has
been shown to be high with larger diameter (>50 mm)
MoM hip replacements [3]. It is not exactly known
whether this is solely due to taper wear and damage due
to corrosion or if edge-loading and subsequent bearing
surface wear also have an affect . Presumably both have an
influence to higher failure rate. Registry studies suggest
significantly higher revision rates with large-diameter
(>50 mm) THR compared to large diameter (>50 mm)
HRs when the same bearing couple is used [7].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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prevalence of ARMD among patients who received a
large-headed (>50 mm) ASR™ XLTHR system at our insti-
tution, and (2) to investigate whether previously identified
risk factors apply to this specific patient population. To
achieve these goals, we used data obtained from a mass
screening programme implemented at our institution for
these patients.Methods
Screening programme
DePuy Orthopaedics voluntarily recalled their ASR™
MOM hip system in August 2010. After the UK Medi-
cines and Healthcare Products Regulatory Agency an-
nounced a medical device alert regarding ASR™ hip
arthroplasty implants in September 2010, our institution
established a mass screening programme to identify pos-
sible articulation-related complications in patients who
had received an ASR™ XL prosthesis during THR at our
institution [1]. The screening process was described in
detail in our earlier study [10]. Briefly, all patients re-
ceived an OHS questionnaire, were referred to whole
blood metal ion (chrome and cobalt) measurements, to
plain hip radiographs as well as to cross-sectional im-
aging. All patients also underwent physical examination
(including HHS) at our outpatient clinic.Study population
One thousand and thirty-six ASR™ MOM hip arthroplas-
ties were performed on 887 patients at our institution be-
tween March 2004 and December 2009. In 554 operations
(473 patients), a femoral head size greater than 50 mm
was used. Of these 473 patients, 196 (225 hips) received
an ASR™ XL THR prosthesis. Stems manufactured by
DePuy were used in all ASR™ XL THRs: a proximally
coated Summit® stem in 149 (66%), a hydroxyapatite-
coated Corail® stem in 53 (24%), and an S-ROM® stem in
21 (9%) operations, respectively. Furthermore, a short
Proxima™ stem was used in two operations (1%). All these
stems were manufactured by the same company (DePuy).
They all have identical 12/14 Morse taper made from
cobalt-chrome alloy. The current literature does not de-
scribe possible differences in surface finish or roughness
of taper between different stem brands. All living patients
who had not had revision surgery with a femoral head size
greater than 50 mm were invited to participate in a
screening programme, and 176 agreed to do so. A written
informed consent was obtained from all patients partici-
pating in this study. We obtained permission to perform
this study from the ethics committee (Regional Ethics
Committee in The Pirkanmaa Hospital District’s Science
Centre) of the hospital district in which the study was
conducted.Surgical technique
All primary operations were performed by or under the
direct supervision of seven experienced hip surgeons (JP,
TP, PH, PK, TM, UP, HS) and according to the standard
protocol at our institution. A posterior approach was
used in all cases and external rotators were detached
along the incision of the posterior capsule and reat-
tached with absorbable sutures through drill holes to the
greater trochanter. Postoperatively patients were allowed
immediate full weight bearing with crutches and without
any major restrictions on movement.
Revisions
Failure was defined as a revision operation secondary to an
adverse reaction to metal debris. Revision surgery was con-
sidered if (1) a clear pseudotumour (Imperial class 2A,2B
or 3) observed on cross-sectional imaging regardless of
symptoms or whole blood metal ion levels; or (2) the pa-
tient had elevated whole blood metal ion levels and hip
symptoms despite a normal finding in cross-sectional im-
aging; or (3) the patient had a continuously symptomatic
hip or progressive symptoms regardless of imaging findings
or metal ion levels. Symptoms included hip pain, discom-
fort, sense of instability, and/or impaired function of the
hip and sounds from the hip (clacking, squeaking). Whole
blood metal ion levels were regarded as being elevated if
either chromium or cobalt exceeded 5 ppb. Diagnosis of
adverse reactions to metal debris was based on periopera-
tive findings. Failure was classified as being secondary to
adverse reactions to metal debris if the following criteria
were met: (1) there was presence of metallosis or macro-
scopic synovitis in the joint; and/or (2) a pseudotumor was
found during revision; and/or (3) a moderate to large
amount of perivascular lymphocytes along with tissue ne-
crosis and/or fibrin deposition was seen in the histopatho-
logic sample; and (4) perioperatively there was no evidence
of component loosening or periprosthetic fracture. Fur-
thermore, infection was ruled out by multiple (at least five)
bacterial cultures obtained during revision surgery.
Cross-sectional imaging
Of all 176 patients attending screening, 172 patients (97%)
underwent cross-sectional imaging. MRI was performed
on 149 patients (172 hips) and ultrasonography in the
remaining 23 patients (27 hips). Two patients (two hips)
died and one patient (one hip) had a late infection prior to
any imaging. One patient declined to undergo any im-
aging. MRI was performed with two 1.5-T machines
(Siemens Magnetom Avanto 1.5 T; Siemens Healthcare,
Erlangen, Germany; and GE Signa HD 1.5 T; General
Electric Healthcare, Waukesha, WI, USA). All examina-
tions were done with coronal and axial T1-weighted
fast spin echo and coronal, axial, and sagittal short tau
inversion recovery.
Table 1 Demographics of the patients
Demographic
Patients (n) Hips (n) 196
225
Age Mean (SD, range) 60.3 (10.3, 25 to 84)
<50 years 25 (15.7%)
≥50 years 171 (84.3%)
Sex Male 181 (92.3%)
Female 15 (7.7%)
Diagnosis Primary OA 145 (64.9%)
Other 80 (35.1%)







Preoperative ROM Mean (SD, range) 124° (22°, 10° to 276°)
<100° 81 (43.4%)
≥100° 131 (56.6%)
Cup coverage Mean (SD, range) 31.4° (6.8°, 10.7° to 52.0°)
<25° 34 (28.1%)
≥25° 191 (71.9)
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cation [16]. In this classification type 1 PT indicates a
PT with thin walls and fluid-like core signal. Class 2A
indicates a PT with thick or irregular walls and a fluid-
like core signal. Class 2B PT refers to PT with thick or
irregular walls and atypical fluid core. Class 3 indicates a
solid PT. MRI scans were analysed by a musculoskeletal
radiologist (co-author PE). In the US examination, pseu-
dotumour was defined as a cystic, thick-walled or solid
extra-articular mass adjacent to the hip joint. US exami-
nations were performed with Logiq e9 (GE Healthcare,
Wisconsin, USA) and graded by the same musculoskel-
etal radiologist.
Metal ion analysis
Whole blood metal ion levels were available for all patients
participating in screening. The protocol for obtaining and
assessing of blood samples has been described earlier [10].
Statistics
Student’s t-test was used when comparing normally dis-
tributed variables between groups and variables violating
this assumption were compared using the Mann-Whitney
U test. For the purposes of the Cox regression analysis
continuous variables were distributed to appropriate sub-
groups. Cup coverage was categorized as described earlier
[10]. For age, a cutoff value of 50 years was used. A cutoff
value of 40 years used by others would have resulted in
too small subgroups, since only 10 patients in our study
group were younger than 40 years [12]. Preoperative total
ROM was divided into two groups based on the mean
value minus ½ SD, which yielded the following distribu-
tion: less than 100° and 100° or greater. Age, preoperative
range of motion (ROM), cup coverage, gender and diagno-
sis (primary osteoarthritis vs. other diagnosis), femoral
diameter as continuous variable and stem type were stud-
ied as risk factors for adverse reactions to metal debris.
The proportion of patients with bilateral implants was
relatively high (29%). There were considerable differences
in the distribution of stem concepts between THR sub-
groups: Summit stem was used in 63% of the operations
in the unilateral THRs, compared of 73% in the bilateral
THRs. The difference was almost significant (Chi-square,
p = .067). If there is an underlying patient susceptibility
predisposing to ARMD, patients with bilateral implants
may be at elevated risk of revision of both hips and this
may result in bias in the analysis due to differences in
component selection. Therefore Cox regression analysis
was performed twice in both implant groups: in the first
stage only unilateral patients were included and in second
stage all patients were included. Cox regression analysis
was used to estimate the the adjusted risk ratios of the dif-
ferent variables on the risk of adverse reactions to metal
debris-related failure. The assumption of proportionalhazards was tested using scaled Schoenfeld residuals.
No violations of the assumption was seen (p > .05). Cox
regression analysis was performed including all vari-
ables in the analysis at the same time. The Wald test
was applied to calculate p values for data obtained from
the Cox multiple regression analysis. Comparison of
survivorship by strata factor was performed using the
log-rank test. The significance level was set at 0.05.
Statistical analyses were conducted with IBM Statistics
Version 19.0 (SPSS, Chicago, IL, USA) and Stata 10
(College Station, TX, USA).
Results
The mean age of patients was 60.3 years (SD 10.3)
(Table 1). Mean follow-up was 5.4 years (SD 2.1) (Table 2).
Clinical outcome scores and measurements are shown in
Table 2.
Revision surgery was performed on 84 hips in 75 pa-
tients (including those revised before the screening
programme). Adverse reaction to metal debris was diag-
nosed in the majority (n = 73 [87%]) of these revisions
(Figure 1). Of the 73 revised hips, 20 evinced a clear PT
(Imperial class 2A, 2B or 3) in pre-revision imaging
(18 MRI, 2 US). In 18 hips (16 MRI, 2 US) there was a
cystic, thin walled PT (Imperial class 1) seen in the
Table 2 Clinical findings of the patients
Mean FU (SD, range) 5.4 yrs (2.1, 0.2 to 8.0)
Median HHS (range) 94 (42 to 100)
Median OHS (range) 43 (12 to 48)
Median WB Co (range)
Unilateral 3.7 ppb (0.5 to 9.10)
Bilateral 9.55 ppb (2.2 to 31.4)
Median WB Cr (range)
Unilateral 1.80 ppb (0.5 to 9.1)
Bilateral 2.70 ppb (1.30 to 9.6)
Cystic PTs (class 1)
in MR 34 (19.8%)
in US 3 (11.1%%)
Thick-walled PTs (class 2A/2B)
in MR 22 (12.8%)
in US 4 (14.8%)
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the pre-revision imaging and in two hips no imaging
was done prior to revision. In addition to 73 revisions
performed for ARMD, six hips (7.1%) were revised be-
cause of deep prosthetic joint infection, two hips
(2.3%) for periprosthetic fracture, two hips (2.3%) forFigure 1 Perioperative findings in a patient undergoing revision
surgery due to suspected ARMD. A) Male taper shows severe corrosion
and fretting. B) Female taper shows moderate fretting and large
amount of cheese-like caseotic (necrotic) tissue inside the head.aseptic loosening of the stem, and one hip (1.1%) for
aseptic loosening of the cup.
The prevalence of adverse reactions to metal debris
was 32%. Including only unilateral patients the preva-
lence of ARMD was 28%. Cumulative 8-year survivor-
ship was 52% (95% CI, 48%-56%) with any revision as
the end point (Figure 2). For revision for ARMD as the
end point, the cumulative 8-year survivorship was 57%
(95% CI, 53%-61%). In the subgroup analyses of the
THR group (only head sizes with more than 20 hips in-
cluded), the poorest survivorship with ARMD as the end
point was seen in hips with femoral diameter of 55 mm
(p = .05) (Figure 3).
Femoral diameter and stem type were independent
risk factors for ARMD in the unilateral THR group
(Table 3). However, no significant risk factors were seen
when bilateral cases were included (Table 3).
Discussion
Small femoral size and reduced cup coverage are known
risk factors for ARMD in patients with HRs but in THRs
there is variation in the factors associated with ARMD
(Table 4) [3,10,11,17,18]. The variation in the variables
included in the analyses is large. Equal failure rates have
been reported for larger diameter (>50 mm) THRs com-
pared to small diameter (<50 mm) HRs [7] However the
exact failure mechanisms have not been specifically re-
ported in larger diameter (>50 mm) MoM hip replace-
ments. Taper junction wear and corrosion are known to
have a significant role in the failure of larger diameter
THR but clinical factors related to taper failure have not
been established [4,19,20]. It is not known whether pre-
viously reported risk factors apply to this subcohort. We
addressed this issue using a systematic screening
programme to determine the risk factors for ARMD
among patients undergoing large-headed (>50 mm)
ASR™ XL THRs at our institution.
A limitation of our study was inadequate assessment
of cup orientation. Extremes of cup version are known
to be associated with an increased risk of adverse reac-
tions to metal debris-related failure. We did not calcu-
late cup version in this study because we lacked
appropriate tools to measure version accurately. Further-
more, our survival analyses face a common orthopaedic
problem since one patient may contribute two hips thus
violating the assumption of independent observations
[21]. We addressed this problem by analysing risk fac-
tors separately for unilateral patients and for the whole
cohort. Finally, not necessarily a limitation but a matter
of the validity of our results is the inclusion of variables
in the risk factor analysis. Several authors have included
serum or WB metal ion levels as a covariate in the regres-
sion analysis. We did not include chrome or cobalt level
as covariates since we aimed at as robust a multivariable
Figure 2 The graph shows the overall survivorship for ASR XL THR cohorts with any revision as the end point. Dotted line indicates number
at risk <20.
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correlate strongly with cup coverage and femoral diam-
eter. Including blood metal ion levels in the analysis could
possibly inflate the influence of other covariates thus
falsely highlighting the importance of elevated metal ion
levels alone. The main interest in the risk factor analysis
was the effect of baseline variables, ie. factors which can
be assessed before or during the primary operation and
which are unrelated to the postoperative outcome or pa-
tient status. Including blood metal ion levels would violate
this research frame. The same applies to other possible co-
variates such as symptoms or patient activity. Presence of
symptoms as well as elevated metal ion levels has a key
role in clinical decision-making and would seriously
impair the power of our multivariable analysis. Moreover
patient activity is likely to be affected by the presence of a
painful pseudotumour. Preoperative patient activity would
definitely have been an interesting covariate but our pre-
operative clinical assessment did not account for this and
therefore we were not able to include it as a covariate.
The 8-year survival rate was 52% in this ASR XL THR
group. This survival rate is comparable to the 6-year sur-
vival rate reported by Langton et al for male patients
who had most likely received larger diameter compo-
nents [5]. Interestingly the 7-year survival rate of 55% inthe THR group in this study almost equals the survival
of HR patients with femoral diameter less than 50 mm
published in our earlier study and is also in accordance
with that recently reported by Jack et al [7,10]. They
found a significantly higher revision rate with large
headed THR compared to large headed HR when an
identical bearing system was used. Furthermore, no dif-
ference was seen in revision rates between large headed
THR and small headed HR in that study.
Increasing femoral size and stem type were significant
risk factors for ARMDIncreasing femoral size as a risk fac-
tor is a somewhat controversial finding. Larger femoral
size allows better cup coverage which leads to better con-
formity between head and cup and a better lubrication re-
gime [13,15]. However, hips with a femoral diameter of
55 mm may exhibit more micromotion at the taper-
trunnion. Micromotion has been shown to damage the
protective passivation layer of the alloy further leading to
fretting and corrosion [20]. Nevertheless, our findings are
in accordance with Langton et al. who reported that the
relationship between the prevalence of ARMD and head
size is a U-shaped curve in ASR THRs [5]. Our findings
are further supported by other results by Langton et al.
who showed a positive correlation between larger femoral
head diameters and taper material loss [4]. Whether CoCr
Figure 3 The graph shows the overall survivorship for ASR XL THR with different femoral sizes with ARMD as the end point. Dotted line indicates
number at risk <20.
Table 3 Results of the multivariable Cox regression analysis for the risk of ARMD in the THR cohort
Unilateral THRs All THRs
Variable HR (95% CI) HR (95% CI)
Sex Male 1.0 (ref) p = .3 2.0 (ref) p = .6
1.26 (0.47 – 3.31)Female 1.82 (0.63 – 5.21)
Age <50 years 1.03 (0.35 – 3.06) p = .9 1.32 (0.56 – 3.12) p = .5
1.0 (ref)≥50 years 1.0 (ref)
Diagnosis OA 1.11 (0.52 – 2.33) p = .8 1.29 (0.68 – 2.44) p = .4
1.0 (ref)Other 1.0 (ref)
Cup coverage <25 degrees 1.0 (ref) p = .2 1.0 (ref) p = .5
1.28 (0.63 – 2.60)≥25 degrees 1.73 (0.70 – 4.33)
Stem Summit 1.0 (ref) p = .04 p = .035 2.0 (ref) p = .061
1.73 (0.97 – 3.06) p = .16
Corail 2.17 (1.03 - 4.56) 0.50 (0.19 – 1.31)
Other 0.26 (0.08 - 0.91)
Femoral diameter 2 mm 1.16 (1.01 - 1.34) p = .035 1.04 (0.94 - 1.15) p = .5
increment
Preoperative ROM <100 degrees 1.0 p = .3 1.0 p = .16
1.46 (0.86 – 2.50)≥100 degrees 1.39 (0.68 – 2.82)
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Table 4 Variables associated with ARMD in patients with large-diameter MoM THRs
Study Patients (hips) Statistics Associated with ARMD Not associated with ARMD





Langton et al. 418 HRs Univariate Small femoral diameter Inclination angle
87 THRs High anteversion angle
Elevated Cr/Co levels
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phenomenon warrants further investigation.
An important and novel finding in our study was also
the absence of any significant effect of reduced cup
coverage for the development of ARMD. This clearly
emphasizes the influence of taper failure in larger-
diameter hip replacements making taper failure inevit-
ably the most important aetiological reason for the
high failure prevalence. The aetiology of taper failure
in larger diameter hip replacement may be purely
mechanical since increased lever arm in the taper junc-
tion is associated with increased material loss in the
taper [4]. Moreover, a simulator study by Panagiotidou
et al. suggests that the coarser and rougher the surface
finish of the taper is, the more likely is the breach of
the passive film resulting in corrosion [22]. Whether
the Corail stem has the coarsest and roughest surface
finish thus being more vulnerable to increased lever arm
in taper junction definitely warrants further research since
the Corail stem is widely used with <40 mm MoM
bearings and with ceramic-on-ceramic bearings.
When bilateral cases were excluded from the multivari-
able regression analysis stem type and increasing femoral
diameter were significant independent risk factors for
ARMD. However, when all cases, both unilateral and bilat-
eral, were included no significant risk factors were identi-
fied. Conceptually the latter analysis had several violations
of assumptions the most important of which is the viola-
tion of the assumption of independent observations as
stated earlier. The major shift in the hazard ratios may also
describe the moderation effect (interaction) betweenfemoral head size and stem type. We assume that this
interaction is mediated through the tribology of the taper.
As stated earlier, tribological studies have shown that the
coarser the surface, the higher the wear [22]. If the Corail
stem were to have coarser surface finish, it would be more
susceptible to damage and wear with increasing femoral
size. Assuming that this association is absent with Summit
stems including bilateral cases in the analysis would
undermine the influence of the Corail stem since the
majority of patients with bilateral hip replacements
had Summit stems. Moreover the significance of in-
creasing femoral head size would be lost due to over-
representation of Summit stems in the study cohort.
Conclusions
We found a high ARMD related failure rate in patients
with large headed ASR XL THRs. Edge-loading due to
reduced cup coverage is not an important failure
mechanism in this cohort. Risk factors for ARMD in
this cohort, however, suggest that taper failure is not a
homogenous mechanism across different taper designs,
surface finish with or without increased lever arm in
the taper junction due to larger head sizes may con-
tribute differently to taper failure. The very same
cobalt-chrome and titanium tapers that have been used
with large heads in MoM hips are seen in a wide range of
other non-MoM THRs. Further research is warranted to
find out, whether the association of taper design with
taper failure is equally prominent in <40 mm MoM
bearings as it is in this subcohort and whether this
phenomenon goes beyond MoM hips.
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